Daniel is the founder of Paperchain. Paperchain delivers early access for streaming revenue to artists, management and label teams.

Charles Koch is a complex person that goes far beyond his political involvement. Even though he grew up among wealthy, Charles learned the value of hard work early in life while working on his dad's farm. There he learned to disregard instant gratification and to focus on the long-term. He also realized that unless he figured out how to be good at something unique, he'd be forever stuck digging dirt with his hands. If you want to hear some honestly brutal life and business advice from one of the world's riches men, this is a good podcast to start with.

How we can store digital data in DNA | Dina Zielinski

The wait is finally over: this week we are very excited to bring you the episode we’ve been teasing for weeks: vaccines! This week and next (you don’t have to wait a full two weeks for the next episode!), we are presenting a two-part series on vaccines. In today’s episode, we dive deep into the biology of vaccines, from how they stimulate your (amazing) immune system to protect you, to how they make you into an almost-superhero, shielding the innocents around you from deadly infections. We take you back hundreds, nay, thousands of years to when something akin to vaccination first began, and then we walk along the long road of vaccine development to see just how massive an impact vaccines have had on the modern world. The best part? We are joined by not one, but two experts from the Bill and Melinda Gates Foundation. Dr. Gail Rodgers and Dr. Padmini Srikantiah explain the process of vaccine development, highlight the challenges of vaccine deployment, and shine a hopeful light on the future of vaccines. And be sure to tune in next week for part 2 where we’ll focus on vaccine hesitancy and address common misconceptions surrounding vaccines in even more depth.

For more information on the Bill and Melinda Gates Foundation initiatives, visit: https://www.gatesfoundation.org/

For more information on vaccines currently in development, check out: https://clinicaltrials.gov/ and https://www.who.int/immunization/research/vaccine_pipeline_tracker_spreadsheet/en/

And, as always, you can find all of the sources we used in this episode on our website: http://thispodcastwillkillyou.com/episodes/

Ashley, in the role of the Riley Reid character, has defied all pornographic convention by embracing body positivity, forgoing plastic surgery and opting for natural body hair at times. Additionally she has made a social statement by doing a popular artistic scene which makes a political and business case for greater transsexual acceptance. Her main tool appears to be a palpable human decency and sweetness coupled to an uncanny ability to asses, manage and survive extreme business risk within a poorly understood industry that has confounded all expectations.

Eric sits down with the business woman to discuss obscenity laws, difficulty of finding vendors willing to work with an erotic businesses, and the challenges of fighting obscenity and indecency charges, among other things. Listener discretion is advised.

Chris goes to London and sits down with Tim Minchin because standing to podcast is weird. Tim talks comedy in Perth, Edinburgh, and the Higgs Boson. Fill your brain with his brilliant musicianship and comedy at timminchin.com.

A football helmet, wire cutters, alcohol, a metal detector, cocaine and superglue? Sounds like a recipe for disaster. 

Really enjoyed sitting down with Yoni, the founder of podcast notes and getting his wisdom about the world of podcasting and how he started it. So interesting!

Scoutzie.com was a marketplace for high-end design where anyone could find and book fantastic professional designers to design apps, websites, and logos. The company formed in 2011 and raised a small seed round, took part in Y Combinator in 2012, but eventually failed to achieve venture-scale growth. As of 2015, the Scoutzie team decided to shut the product down. Kirill and Anthony discuss the experiences, and what’s to come next.